Saturday 17 October 2026
Export CABR’s income statement to Excel — free account
Caring Brands, Inc.
CABR Healthcare Drug Manufacturers Specialty & Generic
Caring Brands, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4,200.00, up 740.0% from fiscal 2024. In the quarter to June 2026, EPS fell 102.0% and free cash flow fell 121.3%, each against the same quarter a year earlier.
1.22
0.07
−5.43%
Follow CABR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (2,006.10%) | 0.00% | 0.00% | 0.00% |
+4 more TTM periods Free account |
|
| (1,033.41%) | (883.42%) | (539.65%) | (176.81%) | ||
ROIC |
0.00% | 0.00% | 0.00% | (67.30%) | |
Return on Tangible Assets |
(647.02%) | (536.74%) | (292.01%) | 534.78% | |
Average Days of Receivables |
— | — | 0.00 | — | |
Free Cash Flow per Share |
(0.25) | (0.14) | (0.12) | (0.07) | |
Free Cash Flow |
(2.26) | (2.00) | (1.69) | (0.90) | |
| Other line items | |||||
Cash ROIC |
254.15% | (6,414.42%) | (39.00%) | (34.55%) | |
Accounts Receivable Turnover |
— | — | 0.00 | — | |
Accounts Payable Turnover |
0.00 | — | 0.00 | — | |
Inventory Turnover |
0.00 | — | 0.00 | — | |
Average Days of Payables |
0.00 | 0.00 | 32,734.74 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 2,458.95 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | — | 0.00% | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 3,516.67% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | — | |
Interest Coverage |
(23.21) | (23.25) | (309.11) | — | |
Operating CF/Net income |
0.23 | 0.21 | 0.27 | 0.32 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.25) | (0.14) | (0.12) | (0.07) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
— | — | 0.00 | — |
Columns are period end dates